Dr. Prashanth R. Sunkureddi, MD

Dr. Sunkureddi practices at Prashanth R. Sunkureddi, M.D., P.A. in League City, Texas.

Dr. Sunkureddi's NPI, 1568445740, was assigned on November 22, 2005. Dr. Sunkureddi graduated from St. George's University School of Medicine in 2001. Dr. Sunkureddi holds Texas license M1374.

Dr. Sunkureddi's primary practice is Prashanth R. Sunkureddi, M.D., P.A., at 3725 E League City Pkwy, League City, TX 77573 in Galveston County. The practice phone is (281) 957-9127.

Dr. Sunkureddi's primary practice is Prashanth R. Sunkureddi, M.D., P.A. in League City, Texas. Dr. Sunkureddi is also affiliated with HCA Houston Healthcare Clear Lake. The medical group on file is Texas Rheumatology. Dmand AI also links Dr. Sunkureddi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sunkureddi practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Sunkureddi's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Sunkureddi is board certified in rheumatology by the American Board of Internal Medicine. Dr. Sunkureddi is licensed in Texas.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, fluid in a joint, gout, joint arthropathy, joint pain and lupus among the conditions Dr. Sunkureddi treats.

CMS data shows 142,214 Medicare services from Dr. Sunkureddi across 31 procedure codes in 2024, for 418 Medicare patients. Medicare paid $1,486,350 for them. Every service was in an office.

CMS counts 418 Medicare patients who saw Dr. Sunkureddi in 2024. The largest group is 65 to 74, with 210 patients. 75% of them have arthritis, and 75% have high cholesterol. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sunkureddi's median patient age at 66, with 80% women.

In 2024, Dr. Sunkureddi wrote 1,820 Medicare Part D claims for 334 patients. 81% of them were for generic drugs. CMS names the drug for 1,633 of them, across 36 drugs with 11 or more claims each, at $1,565,640 in total drug cost. In 2023, CMS named 1,504 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Sunkureddi for performance year 2024, reported as part of a group. Dr. Sunkureddi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 12 papers to Dr. Sunkureddi, published from 2011 to 2019. 2018 was the busiest year, with 3. The most frequent topics are Cost of Illness, Glucocorticoids and Narration. Dr. Sunkureddi has published most often in J Clin Rheumatol. Dr. Sunkureddi's most frequent co-authors are Reeti K. Joshi, MD, PA, Terry Ann Mcnearney, MD and Bruce N. Cronstein, MD.

Dmand AI links Dr. Sunkureddi to 11 clinical trials, 4 of them phase 3 studies. Conditions studied include Arthritis, Rheumatoid, Rheumatic Diseases and Lupus Erythematosus, Systemic. Eli Lilly and Company sponsors the most, 6. Open Payments lists research payments to Dr. Sunkureddi that name 2 trials.

CMS Open Payments shows 2,697 general payments to Dr. Sunkureddi from 54 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 59% of the total. Amgen Inc. paid the most, $90,161. It also lists 24 research payments totaling $38,549 from 2016 to 2020, naming 2 clinical trials.

Dmand AI lists 1 award for Dr. Sunkureddi, most recently CMS Stage 1 EHR in 2013.

Dr. Sunkureddi graduated from St. George's University School of Medicine in 2001. Dr. Sunkureddi is a member of ACP, ACR and ACR.

Dr. Sunkureddi is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.